Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7347219, 10 pages
https://doi.org/10.1155/2017/7347219
Research Article

Bark Extracts of Ceylon Cinnamon Possess Antilipidemic Activities and Bind Bile Acids In Vitro

1Herbal Technology Section (HTS), Modern Research & Development Complex (MRDC), Industrial Technology Institute (ITI), 503A Halbarawa Gardens, Malabe, Sri Lanka
2Department of Zoology, Faculty of Science, University of Colombo, Colombo, Sri Lanka
3Faculty of Allied Health Sciences, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka

Correspondence should be addressed to Sirimal Premakumara Galbada Arachchige; kl.iti@psag

Received 6 March 2017; Revised 13 May 2017; Accepted 1 June 2017; Published 20 July 2017

Academic Editor: Mohammed S. Ali-Shtayeh

Copyright © 2017 Walimuni Prabhashini Kaushalya Mendis Abeysekera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Jacobson, M. Miller, and E. J. Schaefer, “Hypertriglyceridemia and cardiovascular risk reduction,” Clinical Therapeutics, vol. 29, no. 5, pp. 763–777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Thayyil, M. K. M. Surulivel, M. F. Ahmed et al., “Hypolipidemic activity of Luffa Aegiptiaca fruits in cholesterol fed hypercholesterolemic rabbits,” International Journal of Pharmaceutical Applications, vol. 2, no. 1, pp. 81–88, 2011. View at Google Scholar
  3. A. S. Fauci, E. Braunwald, D. L. Kasper et al., “Disorders of intermediary metabolism,” in Harrison’s Principles of Internal Medicine, A. S. Fauci, E. Braunwald, D. L. Kasper et al., Eds., pp. 2426–2429, McGraw-Hill, New York, NY, USA, 17th edition, 2008. View at Publisher · View at Google Scholar
  4. N. J. Stone, “Lipid management: Current diet and drug treatment options,” American Journal of Medicine, vol. 101, no. 4 A, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Uchiyama, Y. Taniguchi, A. Saka, A. Yoshida, and H. Yajima, “Prevention of diet-induced obesity by dietary black tea polyphenols extract in vitro and in vivo,” Nutrition, vol. 27, no. 3, pp. 287–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. M. Speight, Avery’s Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics, Williams and Wilkins, Baltimore, Md, USA, 3rd edition, 1987.
  7. I. Ikeda, T. Yamahira, M. Kato, and A. Ishikawa, “Black-tea polyphenols decrease micellar solubility of cholesterol in vitro and intestinal absorption of cholesterol in rats,” Journal of Agricultural and Food Chemistry, vol. 58, no. 15, pp. 8591–8595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Kumar, A. T. S. M. Umamaheswari, V. Subhadradevi et al., “Cholesterol esterase enzyme inhibitory and antioxidant activities of leaves of Camellia sinensis (L.) Kuntze. using in vitro models,” International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 10, pp. 2675–2680, 2011. View at Google Scholar
  9. S. Adisakwattana, J. Intrawangso, A. Hemrid et al., “Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization and bind bile acids,” Food Technology and Biotechnology, vol. 50, no. 1, pp. 11–16, 2012. View at Google Scholar · View at Scopus
  10. P. Ranasinghe, R. Jayawardana, P. Galappaththy, G. R. Constantine, N. de Vas Gunawardana, and P. Katulanda, “Efficacy and safety of “true” cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis,” Diabetic Medicine, vol. 29, no. 12, pp. 1480–1492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Chen, J. Sun, and P. Ford, “Differentiation of the four major species of cinnamons (C. burmannii, C. verum, C. cassia, and C. loureiroi) using a flow injection mass spectrometric (FIMS) fingerprinting method,” Journal of Agricultural and Food Chemistry, vol. 62, no. 12, pp. 2516–2521, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Anonymous, AgStat: Pocket Book of Agricultural Statistics, vol. 10, Socio Economic and Planning Centre, Department of Agriculture, Peradeniya, Sri Lanka, 2013.
  13. R. Hamidpour, M. Hamidpour, S. Hamidpour, and M. Shahlari, “Cinnamon from the selection of traditional applications to its novel effects on the inhibition of angiogenesis in cancer cells and prevention of Alzheimer's disease, and a series of functions such as antioxidant, anticholesterol, antidiabetes, antibacterial, antifungal, nematicidal, acaracidal, and repellent activities,” Journal of Traditional and Complementary Medicine, vol. 5, no. 2, pp. 66–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. Anonymous, Ayurveda Pharmacopoeia, vol. 1 of part 3, Department of Ayurveda, Colombo, Sri Lanka, 1976.
  15. D. M. A. Jayaweera, Medicinal Plants (Indigenous and Exotic) Used in Ceylon, part 3, 1982.
  16. X. Sheng, Y. Zhang, Z. Gong, C. Huang, and Y. Q. Zang, “Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors,” PPAR Research, vol. 2008, Article ID 581348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-S. Lee, S.-M. Jeon, E.-M. Park et al., “Cinnamate Supplementation Enhances Hepatic Lipid Metabolism and Antioxidant Defense Systems in High Cholesterol-Fed Rats,” Journal of Medicinal Food, vol. 6, no. 3, pp. 183–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Hassan, R. Barthwal, M. S. Nair et al., “Aqueous bark extract of Cinnamomum zeylanicum: a potential therapeutic agent for streptozotocin- induced type 1 diabetes mellitus (T1DM) rats,” Tropical Journal of Pharmaceutical Research, vol. 11, no. 3, pp. 429–435, 2012. View at Google Scholar · View at Scopus
  19. I. Javed, I. Faisal, Z. Rahman et al., “Lipid lowering effect of Cinnamomum zeylanicum in hyperlipidaemic albino rabbits,” Pakistan Journal of Pharmaceutical Sciences, vol. 25, no. 1, pp. 141–147, 2012. View at Google Scholar · View at Scopus
  20. C. Kirana, P. F. Rogers, L. E. Bennett, M. Y. Abeywardena, and G. S. Patten, “Naturally derived micelles for rapid in vitro screening of potential cholesterol-lowering bioactives,” Journal of Agricultural and Food Chemistry, vol. 53, no. 11, pp. 4623–4627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Pietsch and M. Gütschow, “Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition,” Journal of Medicinal Chemistry, vol. 48, no. 26, pp. 8270–8288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. S. Kim, Y. M. Lee, H. Kim et al., “Anti-obesity effect of Morus bombycis root extract: Anti-lipase activity and lipolytic effect,” Journal of Ethnopharmacology, vol. 130, no. 3, pp. 621–624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Sri Lanka Standards Institution (SLSI), “Specification for Ceylon cinnamon: Sri Lanka standards,” Colombo, Sri Lanka, 4th revision.81:2010.
  24. W. P. K. M. Abeysekera, G. A. S. Premakumara, and W. D. Ratnasooriya, “In vitro antioxidant properties of bark and leaf extracts of Ceylon Cinnamon (Cinnamomum zeylanicum Blume,” Tropical Agricultural Research, vol. 24, no. 2, pp. 128–138, 2013. View at Google Scholar
  25. J. A. Friesen and V. W. Rodwell, “The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases,” Genome Biology, vol. 5, no. 11, article no. 248, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Corsini, F. M. Maggi, and A. L. Catapano, “Pharmacology of competitive inhibitors of HMg-CoA reductase,” Pharmacological Research, vol. 31, no. 1, pp. 9–27, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Carbonell and E. Freire, “Binding thermodynamics of statins to HMG-CoA reductase,” Biochemistry, vol. 44, no. 35, pp. 11741–11748, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Wang, L. Bao, W. Xiong et al., “Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase,” Journal of Natural Products, vol. 78, no. 8, pp. 1977–1989, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Wang, L. Bao, K. Ma et al., “A novel class of α-glucosidase and HMG-CoA reductase inhibitors from Ganoderma leucocontextum and the anti-diabetic properties of ganomycin I in KK-Ay mice,” European Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. B. P. Lopes, T. G. Gaique, L. L. Souza et al., “Cinnamon extract improves the body composition and attenuates lipogenic processes in the liver and adipose tissue of rats,” Food and Function, vol. 6, no. 10, pp. 3257–3265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. W. P. K. M. Abeysekera, G. A. S. Premakumara, and W. D. Ratnasooriya, “Proanthocyanidins and selected phenolic and non phenolic compounds in bark and leaf of Ceylon cinnamon (Cinnamomum zeylanicum Blume),” in Proceedings of the 72nd Annual Sessions, p. 96, Sri Lanka Association for the Advancement of Science, Colombo, Sri Lanka, 2016.
  32. A. O. Ademosun, G. Oboh, S. Passamonti et al., “Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA.Hy 926 cells,” Food Science and Human Wellness, vol. 4, no. 2, pp. 80–85, 2015. View at Publisher · View at Google Scholar
  33. J. Iqbal and M. M. Hussain, “Intestinal lipid absorption,” American Journal of Physiology - Endocrinology and Metabolism, vol. 296, no. 6, pp. E1183–E1194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. B. Birari and K. K. Bhutani, “Pancreatic lipase inhibitors from natural sources: unexplored potential,” Drug Discovery Today, vol. 12, no. 19-20, pp. 879–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ballinger and S. R. Peikin, “Orlistat: its current status as an anti-obesity drug,” European Journal of Pharmacology, vol. 440, no. 2-3, pp. 109–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. N. A. Lunagariya, N. K. Patel, S. C. Jagtap et al., “Review article: inhibitors of pancreatic lipase: state of the art and clinical perspectives,” EXCLI Journal, vol. 13, pp. 897–921, 2014. View at Google Scholar · View at Scopus
  37. S. Ngamukote, K. Mäkynen, T. Thilawech, and S. Adisakwattana, “Cholesterol-lowering activity of the major polyphenols in grape seed,” Molecules, vol. 16, no. 6, pp. 5054–5061, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Gholamhoseinian, B. Shahouzebi, and F. Sharifi-far, “Inhibitory effect of some plant extracts on pancreatic lipase,” International Journal of Pharmacology, vol. 6, no. 1, pp. 18–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. C. E. McCrea, S. G. West, P. M. Kris-Etherton et al., “Effects of culinary spices and psychological stress on postprandial lipemia and lipase activity: Results of a randomized crossover study and in vitro experiments,” Journal of Translational Medicine, vol. 13, no. 1, article no. 7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Vermeer, T. P. J. Mulder, and H. O. F. Molhuizen, “Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles,” Journal of Agricultural and Food Chemistry, vol. 56, no. 24, pp. 12031–12036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. C. Myers-Payne, D. Y. Hui, H. L. Brockman, and F. Schroeder, “Cholesterol esterase: A cholesterol transfer protein,” Biochemistry, vol. 34, no. 12, pp. 3942–3947, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Insull Jr., “Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: A scientific review,” Southern Medical Journal, vol. 99, no. 3, pp. 257–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Y. Hui and P. N. Howles, “Molecular mechanisms of cholesterol absorption and transport in the intestine,” Seminars in Cell and Developmental Biology, vol. 16, no. 2, pp. 183–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Jin, Y. Xu, X. Mei et al., “Antiobesity and lipid lowering effects of theaflavins on high-fat diet induced obese rats,” Journal of Functional Foods, vol. 5, no. 3, pp. 1142–1150, 2013. View at Publisher · View at Google Scholar · View at Scopus